Profund Advisors LLC Alkermes Plc. Transaction History

Profund Advisors LLC

  • $2.59 Billion
  • Q3 2024

A detailed history of Profund Advisors LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Profund Advisors LLC holds 56,916 shares of ALKS stock, worth $1.64 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
56,916
Previous 59,869 4.93%
Holding current value
$1.64 Million
Previous $1.44 Million 10.47%
% of portfolio
0.06%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$23.01 - $28.55 $67,948 - $84,308
-2,953 Reduced 4.93%
56,916 $1.59 Million
Q2 2024

Aug 13, 2024
BUY
$23.21 - $27.24 $70,117 - $82,292
3,021 Added 5.31%
59,869 $1.44 Million
Q1 2024

May 08, 2024
SELL
$26.4 - $32.56 $220,888 - $272,429
-8,367 Reduced 12.83%
56,848 $1.54 Million
Q4 2023

Feb 14, 2024
BUY
$23.37 - $28.68 $258,121 - $316,770
11,045 Added 20.39%
65,215 $1.81 Million
Q3 2023

Nov 13, 2023
BUY
$27.17 - $31.97 $94,633 - $111,351
3,483 Added 6.87%
54,170 $1.52 Million
Q2 2023

Aug 10, 2023
BUY
$28.34 - $33.63 $29,870 - $35,446
1,054 Added 2.12%
50,687 $1.59 Million
Q1 2023

May 11, 2023
BUY
$25.31 - $29.02 $693,924 - $795,641
27,417 Added 123.41%
49,633 $1.4 Million
Q4 2022

Feb 02, 2023
BUY
$21.94 - $26.24 $9,587 - $11,466
437 Added 2.01%
22,216 $580,000
Q3 2022

Nov 04, 2022
SELL
$22.0 - $31.87 $8,096 - $11,728
-368 Reduced 1.66%
21,779 $486,000
Q2 2022

Aug 01, 2022
SELL
$26.4 - $30.54 $72,362 - $83,710
-2,741 Reduced 11.01%
22,147 $660,000
Q1 2022

May 10, 2022
SELL
$23.07 - $27.99 $63,973 - $77,616
-2,773 Reduced 10.02%
24,888 $655,000
Q4 2021

Feb 08, 2022
SELL
$21.47 - $32.08 $68,575 - $102,463
-3,194 Reduced 10.35%
27,661 $643,000
Q3 2021

Nov 12, 2021
SELL
$23.37 - $32.13 $28,978 - $39,841
-1,240 Reduced 3.86%
30,855 $952,000
Q2 2021

Aug 12, 2021
BUY
$18.78 - $25.15 $75,927 - $101,681
4,043 Added 14.41%
32,095 $787,000
Q1 2021

May 14, 2021
SELL
$18.21 - $23.2 $79,686 - $101,523
-4,376 Reduced 13.49%
28,052 $524,000
Q4 2020

Feb 09, 2021
BUY
$15.39 - $22.1 $44,123 - $63,360
2,867 Added 9.7%
32,428 $647,000
Q3 2020

Nov 13, 2020
SELL
$16.16 - $20.66 $90,803 - $116,088
-5,619 Reduced 15.97%
29,561 $490,000
Q2 2020

Aug 03, 2020
BUY
$13.31 - $19.41 $74,389 - $108,482
5,589 Added 18.89%
35,180 $683,000
Q1 2020

May 15, 2020
SELL
$13.06 - $21.24 $141,087 - $229,455
-10,803 Reduced 26.74%
29,591 $427,000
Q4 2019

Feb 18, 2020
BUY
$17.29 - $21.74 $73,205 - $92,047
4,234 Added 11.71%
40,394 $824,000
Q3 2019

Nov 12, 2019
SELL
$19.51 - $24.28 $48,579 - $60,457
-2,490 Reduced 6.44%
36,160 $705,000
Q2 2019

Aug 13, 2019
SELL
$21.47 - $37.33 $103,635 - $180,191
-4,827 Reduced 11.1%
38,650 $871,000
Q1 2019

May 15, 2019
BUY
$28.4 - $36.49 $22,805 - $29,301
803 Added 1.88%
43,477 $1.59 Million
Q4 2018

Feb 14, 2019
SELL
$27.94 - $44.61 $290,659 - $464,077
-10,403 Reduced 19.6%
42,674 $1.26 Million
Q3 2018

Nov 13, 2018
BUY
$38.6 - $46.12 $189,757 - $226,725
4,916 Added 10.21%
53,077 $2.25 Million
Q2 2018

Aug 13, 2018
SELL
$40.56 - $51.36 $148,125 - $187,566
-3,652 Reduced 7.05%
48,161 $1.98 Million
Q1 2018

May 14, 2018
SELL
$53.61 - $67.26 $245,801 - $308,387
-4,585 Reduced 8.13%
51,813 $3 Million
Q4 2017

Feb 14, 2018
SELL
$47.69 - $55.39 $344,226 - $399,805
-7,218 Reduced 11.35%
56,398 $3.09 Million
Q3 2017

Nov 13, 2017
BUY
$49.16 - $54.45 $258,630 - $286,461
5,261 Added 9.02%
63,616 $3.23 Million
Q2 2017

Aug 11, 2017
BUY
N/A
58,355
58,355 $3.38 Million

Others Institutions Holding ALKS

# of Institutions
361
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email